Switzerland reviews third anti-viral Covid vaccine

2020-11-13 02:59:44

Alternative Headline:

(MENAFN- Swissinfo) The Swiss therapeutics products agency Swissmedic has started a review of another anti-Covid 19 vaccine – this time from United States biotech firm Moderna - in the rolling submission procedure.

This content was published on November 13, 2020 - 14:03 November 13, 2020 - 14:03 Keystone-SDA/Swissmedic/SWI swissinfo.ch/ilj

This is the third authorisation procedure submitted in Switzerland for a vaccine against the novel coronavirus.

'The rolling submission procedure for mRNA-1273 is based on the initially submitted data packages on the preclinical situation and quality, as well as on preliminary clinical data. In a rolling review, the data can be evaluated as soon as they become available. The companies can then submit the latest data continuously without having to wait for the conclusive results from all studies,' Swissmedic said on Friday .

Swissmedic can thus obtain an initial picture of the benefit-risk profile of the vaccine candidates before the authorisation studies are completed (Phase III studies). This accelerates the review process while at the same time 'preserving the same level of careful checking of all requirements relating to safety, efficacy and quality', it explained.

MENAFN13112020000210011054ID1101122395

Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.